NZD 0.03
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 2.41 Million NZD | -81.42% |
2023 | 13.01 Million NZD | 46.0% |
2022 | 8.91 Million NZD | 24.99% |
2021 | 7.13 Million NZD | 72.85% |
2020 | 4.12 Million NZD | 86.74% |
2019 | 2.21 Million NZD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 FY | 2.41 Million NZD | -81.42% |
2024 Q2 | 556.25 Thousand NZD | -89.93% |
2024 Q4 | 128.8 Thousand NZD | 0.0% |
2024 Q1 | 5.52 Million NZD | 827.34% |
2023 FY | 13.01 Million NZD | 46.0% |
2023 Q2 | 970.21 Thousand NZD | 279.75% |
2023 Q4 | 595.87 Thousand NZD | -82.93% |
2023 Q1 | 255.48 Thousand NZD | -80.75% |
2023 Q3 | 3.49 Million NZD | 259.79% |
2022 Q1 | 1.94 Million NZD | -38.67% |
2022 FY | 8.91 Million NZD | 24.99% |
2022 Q4 | 1.32 Million NZD | -37.08% |
2022 Q3 | 2.1 Million NZD | -45.62% |
2022 Q2 | 3.87 Million NZD | 99.91% |
2021 FY | 7.13 Million NZD | 72.85% |
2021 Q4 | 3.16 Million NZD | 89.28% |
2021 Q3 | 1.67 Million NZD | -51.9% |
2021 Q2 | 3.47 Million NZD | 116.77% |
2021 Q1 | 1.6 Million NZD | -33.65% |
2020 FY | 4.12 Million NZD | 86.74% |
2020 Q2 | 2.04 Million NZD | 136.2% |
2020 Q4 | 2.41 Million NZD | 156.86% |
2020 Q1 | 867.06 Thousand NZD | 0.0% |
2020 Q3 | 940.7 Thousand NZD | -54.07% |
2019 FY | 2.21 Million NZD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AFT Pharmaceuticals Limited | 64.03 Million NZD | 96.221% |
Greenfern Industries Limited | 1.71 Million NZD | -40.878% |